1,578 results on '"Barnholtz-Sloan, Jill S."'
Search Results
152. Supplementary Figure 1 from Aberrant Vimentin Methylation Is Characteristic of Upper Gastrointestinal Pathologies
153. Supplemental Table S1 from Methylated B3GAT2 and ZNF793 Are Potential Detection Biomarkers for Barrett's Esophagus
154. Supplementary Table 6 from Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma
155. Data from Aberrant Vimentin Methylation Is Characteristic of Upper Gastrointestinal Pathologies
156. Supplementary Table 1 from Aberrant Vimentin Methylation Is Characteristic of Upper Gastrointestinal Pathologies
157. Supplementary Table 5 from Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma
158. Supplementary Figure 1 from A Variable Age of Onset Segregation Model for Linkage Analysis, with Correction for Ascertainment, Applied to Glioma
159. Supplementary Data from 5-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against PIK3CA-Mutant Colorectal Cancers
160. Supplementary Data from Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma
161. Supplementary Figures from RNA Sequencing Identifies Transcriptionally Viable Gene Fusions in Esophageal Adenocarcinomas
162. Supplementary Figure 2 from A Variable Age of Onset Segregation Model for Linkage Analysis, with Correction for Ascertainment, Applied to Glioma
163. Data from Methylated B3GAT2 and ZNF793 Are Potential Detection Biomarkers for Barrett's Esophagus
164. Data from Single-Nucleotide Polymorphisms in Nucleotide Excision Repair Genes, Cigarette Smoking, and the Risk of Head and Neck Cancer
165. Supplementary Table 2 from Aberrant Vimentin Methylation Is Characteristic of Upper Gastrointestinal Pathologies
166. Supplementary Figure 2 from Aberrant Vimentin Methylation Is Characteristic of Upper Gastrointestinal Pathologies
167. Supplementary Methods and Materials. Supplementary Tables S1-S4 from Predicting Barrett's Esophagus in Families: An Esophagus Translational Research Network (BETRNet) Model Fitting Clinical Data to a Familial Paradigm
168. Genetic Factors Associated with Absolute and Relative Plasma Concentrations of Calcitriol
169. Mortality trends in primary malignant brain and central nervous system tumors vary by histopathology, age, race, and sex
170. The association of Medicaid expansion and pediatric cancer overall survival
171. Allostatic load and cardiovascular outcomes in males with prostate cancer
172. The impact of the COVID-19 pandemic on treatment patterns in glioblastoma.
173. Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma
174. Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett’s esophagus
175. Brain metastases: epidemiology
176. Publisher Correction: Mendelian randomisation study of the relationship between vitamin D and risk of glioma
177. Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium.
178. Complete prevalence of primary malignant and nonmalignant brain tumors in comparison to other cancers in the United States.
179. Author Correction: Federated learning enables big data for rare cancer boundary detection
180. Racial disparities in breast cancer treatment patterns and treatment related adverse events
181. Medicaid expansion is associated with increased 1-year survival for primary malignant brain tumors
182. Epidemiology of Intracranial Gliomas
183. Cancer risk among HIV-exposed uninfected children in the United States
184. Corrigendum to: Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States
185. Expanding our knowledge of brain tumor overall survival trends at a global scale
186. Federated learning enables big data for rare cancer boundary detection
187. Sex Biases in Cancer and Autoimmune Disease Incidence Are Strongly Positively Correlated with Mitochondrial Gene Expression across Human Tissues
188. Sex differences in adults with acute myeloid leukemia and the impact of sex on overall survival
189. Racial Differences in Chronic Stress/Allostatic Load Variation Due to Androgen Deprivation Therapy in Prostate Cancer
190. Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation
191. Do race and age vary in non-malignant central nervous system tumor incidences in the United States?
192. Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013
193. The ratio of HLA-DR and VNN2+ expression on CD14+ myeloid derived suppressor cells can distinguish glioblastoma from radiation necrosis patients
194. Estimating the annual frequency of synchronous brain metastasis in the United States 2010–2013: a population-based study
195. Is mortality due to primary malignant brain and other central nervous system tumors decreasing?
196. Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors
197. Incidence and survival trends in oligodendrogliomas and anaplastic oligodendrogliomas in the United States from 2000 to 2013: a CBTRUS Report
198. Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects
199. Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
200. Molecular marker testing and reporting completeness for adult-type diffuse gliomas in the United States
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.